Time: 1250 – 1350hrs (lunch provided in hall)
Venue: Theatrette, Exhibition Hall
Chair: Dr. Kenneth Chan (Singapore)
Current Toolbox for treating Multidrug Resistant Pathogens in the ICU: Focus on Nosocomial Pneumonia
Dr. Michael Niederman (USA)
Nosocomial Pneumonia in Ventilated Patients: Ceftolozane/Tazobactam Versus Meropenem (ASPECT-NP Study)
Dr. Ricard Ferrer (Spain)
During this one-hour satellite symposium, Dr. Michael Niederman will discuss the disease burden of selected multi-drug resistant pathogens, focusing on nosocomial pneumonia in intensive care units . The audience will gain insights into the limitations of current treatment options available from various perspectives. Dr. Ricard Ferrer will then describe the recent ASPECT-NP study in nosocomial pneumonia, first presenting the study design, inclusion/exclusion criteria, patient demographic data, and primary/secondary end point results, and then reviewing the mortality, clinical cure and microbiology response results.